Martingale Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.5M | Buy |
480,418
+6,000
| +1% | +$160K | 0.34% | 103 |
|
|
2025
Q4 | $11.8M | Sell |
474,418
-31,190
| -6% | -$787K | 0.3% | 110 |
|
|
2025
Q3 | $12.9M | Sell |
505,608
-54,600
| -10% | -$1.35M | 0.32% | 107 |
|
|
2025
Q2 | $13.6M | Buy |
560,208
+35,020
| +7% | +$817K | 0.33% | 105 |
|
|
2025
Q1 | $13.3M | Buy |
525,188
+398,059
| +313% | +$10.4M | 0.34% | 103 |
|
|
2024
Q4 | $3.37M | Buy |
127,129
+102,521
| +417% | +$2.78M | 0.08% | 191 |
|
|
2024
Q3 | $712K | Buy |
24,608
+15
| +0.1% | +$438 | 0.02% | 545 |
|
|
2024
Q2 | $688K | Buy |
24,593
+3
| +0% | +$83 | 0.01% | 533 |
|
|
2024
Q1 | $682K | Sell |
24,590
-220,650
| -90% | -$6.12M | 0.01% | 552 |
|
|
2023
Q4 | $7.06M | Sell |
245,240
-923,998
| -79% | -$27.9M | 0.14% | 147 |
|
|
2023
Q3 | $38.8M | Sell |
1,169,238
-66,335
| -5% | -$2.35M | 0.82% | 29 |
|
|
2023
Q2 | $45.3M | Sell |
1,235,573
-13,910
| -1% | -$541K | 0.89% | 24 |
|
|
2023
Q1 | $51M | Buy |
1,249,483
+37,563
| +3% | +$1.62M | 0.98% | 12 |
|
|
2022
Q4 | $62.1M | Sell |
1,211,920
-76,827
| -6% | -$3.68M | 1.21% | 8 |
|
|
2022
Q3 | $56.4M | Buy |
1,288,747
+22,482
| +2% | +$1.09M | 1.12% | 12 |
|
|
2022
Q2 | $66.4M | Sell |
1,266,265
-64,977
| -5% | -$3.31M | 1.21% | 8 |
|
|
2022
Q1 | $68.9M | Sell |
1,331,242
-148,558
| -10% | -$7.71M | 1.03% | 15 |
|
|
2021
Q4 | $87.4M | Buy |
1,479,800
+112,107
| +8% | +$5.55M | 1.12% | 12 |
|
|
2021
Q3 | $58.8M | Sell |
1,367,693
-96,294
| -7% | -$4.27M | 0.77% | 33 |
|
|
2021
Q2 | $57.3M | Sell |
1,463,987
-547,724
| -27% | -$21.3M | 0.65% | 53 |
|
|
2021
Q1 | $72.9M | Sell |
2,011,711
-228,368
| -10% | -$8.11M | 0.84% | 26 |
|
|
2020
Q4 | $82.5M | Buy |
2,240,079
+153,118
| +7% | +$5.62M | 0.94% | 22 |
|
|
2020
Q3 | $72.7M | Sell |
2,086,961
-33,635
| -2% | -$1.18M | 0.87% | 23 |
|
|
2020
Q2 | $65.8M | Buy |
2,120,596
+180,207
| +9% | +$6.12M | 0.78% | 21 |
|
|
2020
Q1 | $60.1M | Buy |
1,940,389
+472,914
| +32% | +$16.1M | 0.8% | 18 |
|
|
2019
Q4 | $54.6M | Buy |
1,467,475
+7,174
| +0.5% | +$256K | 0.56% | 37 |
|
|
2019
Q3 | $49.8M | Sell |
1,460,301
-252,876
| -15% | -$9.2M | 0.51% | 50 |
|
|
2019
Q2 | $70.4M | Sell |
1,713,177
-90,078
| -5% | -$3.58M | 0.74% | 18 |
|
|
2019
Q1 | $72.7M | Buy |
1,803,255
+72,383
| +4% | +$2.9M | 0.79% | 10 |
|
|
2018
Q4 | $71.7M | Sell |
1,730,872
-112,998
| -6% | -$4.69M | 0.95% | 4 |
|
|
2018
Q3 | $77.1M | Buy |
1,843,870
+41,595
| +2% | +$1.6M | 0.9% | 7 |
|
|
2018
Q2 | $62M | Buy |
1,802,275
+17,049
| +1% | +$583K | 0.76% | 10 |
|
|
2018
Q1 | $60.1M | Buy |
1,785,226
+478,090
| +37% | +$16.4M | 0.77% | 12 |
|
|
2017
Q4 | $44.9M | Buy |
1,307,136
+107,044
| +9% | +$3.65M | 0.6% | 30 |
|
|
2017
Q3 | $40.6M | Buy |
1,200,092
+107,089
| +10% | +$3.44M | 0.55% | 38 |
|
|
2017
Q2 | $34.8M | Buy |
1,093,003
+112,451
| +11% | +$3.55M | 0.49% | 53 |
|
|
2017
Q1 | $31.8M | Sell |
980,552
-446,258
| -31% | -$14.1M | 0.46% | 64 |
|
|
2016
Q4 | $44M | Sell |
1,426,810
-496,224
| -26% | -$15.1M | 0.62% | 26 |
|
|
2016
Q3 | $61.8M | Buy |
1,923,034
+856,116
| +80% | +$28.6M | 0.92% | 12 |
|
|
2016
Q2 | $35.6M | Sell |
1,066,918
-193,028
| -15% | -$6.16M | 0.59% | 39 |
|
|
2016
Q1 | $35.4M | Sell |
1,259,946
-420,928
| -25% | -$12M | 0.7% | 22 |
|
|
2015
Q4 | $51.5M | Buy |
1,680,874
+59,255
| +4% | +$1.86M | 1.14% | 8 |
|
|
2015
Q3 | $48.3M | Buy |
1,621,619
+57,834
| +4% | +$1.85M | 1.18% | 6 |
|
|
2015
Q2 | $49.7M | Buy |
1,563,785
+156,434
| +11% | +$5.1M | 1.16% | 7 |
|
|
2015
Q1 | $46.5M | Buy |
1,407,351
+4,536
| +0.3% | +$144K | 1.11% | 7 |
|
|
2014
Q4 | $41.5M | Buy |
1,402,815
+65,352
| +5% | +$1.87M | 1.15% | 7 |
|
|
2014
Q3 | $37.5M | Buy |
1,337,463
+163,267
| +14% | +$4.58M | 1.17% | 9 |
|
|
2014
Q2 | $33.1M | Buy |
1,174,196
+103,157
| +10% | +$2.94M | 1.03% | 10 |
|
|
2014
Q1 | $32.6M | Buy |
1,071,039
+162,900
| +18% | +$4.86M | 1.11% | 7 |
|
|
2013
Q4 | $26.4M | Buy |
908,139
+122,825
| +16% | +$3.57M | 0.92% | 10 |
|
|
2013
Q3 | $21.4M | Sell |
785,314
-221,662
| -22% | -$6.03M | 0.76% | 16 |
|
|
2013
Q2 | $26.8M | Buy |
+1,006,976
| New | +$27.8M | 0.99% | 10 |
|
Other funds holding PFE
VCM
VPM
Martingale Asset Management's PFE Position: Q1 2026 in Review
Martingale Asset Management increased its Pfizer (PFE) stake by 1.3% in Q1 2026, buying an estimated $160K and bringing the position to 480,418 shares worth $13.5M. The position accounts for 0.34% of the portfolio, ranked #103.
Martingale Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $87.4M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Martingale Asset Management held 480,418 shares of Pfizer worth $13.5M as of Q1 2026.
- Martingale Asset Management bought 6,000 Pfizer shares in Q1 2026, an estimated $160K.
- Pfizer made up 0.34% of Martingale Asset Management's portfolio in Q1 2026, its #103 holding.
- Martingale Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Martingale Asset Management's Pfizer position peaked at $87.4M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.